GLNCY News Alert Glencore International Plc (GLNCY) 8.8500 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 8:37 PM

Glencore International Plc (GLNCY) 8.8500 $GLNCY

Rio Tinto has no major acquisition plans, CEO says
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 10:59AM CST

FCX: 20.29 (+0.82), RIO: 49.37 (+2.22)

Guinea to auction part of massive Simandou iron ore deposit
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 1:38PM CST

VALE: 8.05 (+0.32), RIO: 49.37 (+2.22)

Wall Street Breakfast: Apple's Market Cap Closes Above $700B
Wall Street Breakfast - at Seeking Alpha - Wed Feb 11, 5:30AM CST

TSLA: 203.77 (+0.89), VRX: 167.00 (-0.50), AMX: 21.97 (+0.27), HAL: 44.19 (+1.42), PBR: 6.98 (+0.44), ANTM: 141.05 (-0.95), FSLR: 48.84 (-0.58), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), ARMH: 49.92 (-0.49), MSFT: 43.87 (+0.78), AAPL: 127.08 (+0.62), INTU: 90.25 (+0.86)

Glencore to divest Lonmin stake; cuts expenditure
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:07AM CST

Zambian president seeks to end mining tax dispute
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 10:21AM CST

ABX: 12.14 (+0.01)

European Stocks Rise as Greek Government Backs Down From Debt Cut Request
at The Street - Tue Feb 03, 5:22AM CST
European stocks rise Tuesday as the new Greek government looks to be backing down from a confrontation with euro-area leaders over a debt write-down.
SAN: 7.18 (+0.13), BHP: 51.19 (+2.38), BP: 41.93 (+0.59)

Glencore considers cuts to South African coal units
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 1:12PM CST

Bloomberg: Glencore may look at upcoming BHP spinoff
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 11:29AM CST

BHP: 51.19 (+2.38)

Mining stocks sell off on gloomy global growth outlook
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 6:57AM CST

RTM: 90.31 (+0.95), XLB: 51.44 (+0.43), MXI: 59.44 (+0.75), FCX: 20.29 (+0.82), UYM: 53.97 (+1.01), SBM: 24.88 (unch), GRES: 27.30 (+0.43), FMAT: 28.92 (+0.27), BHP: 51.19 (+2.38), MATL: 71.97 (+1.25), SLX: 35.20 (+1.14), RIO: 49.37 (+2.22), X: 26.36 (+1.12), GUNR: 32.32 (+0.54), IRV: 21.25 (unch), CCXE: 26.27 (+0.47), CU: 17.35 (+0.60), NUE: 48.90 (+0.55), IYM: 86.13 (+0.83), FXZ: 32.53 (+0.29), PICK: 15.75 (+0.35), COPX: 7.00 (+0.25), HAP: 35.36 (+0.59), SMN: 26.75 (-0.53), CRBQ: 40.87 (+0.92), VALE: 8.05 (+0.32), GNR: 46.15 (+0.69), PYZ: 55.47 (+0.36), XME: 29.95 (+0.63), VAW: 112.81 (+1.05)

Live Long And Prosper: The Beauty Of Low-Cost Production
Andrew Hecht - at Seeking Alpha - Tue Jan 13, 5:05AM CST

DAG: 4.69 (+0.06), OLO: 7.58 (+0.02), BNO: 23.05 (+0.78), TAGS: 30.30 (+0.45), UAG: 21.09 (+0.09), BHP: 51.19 (+2.38), DNO: 54.24 (-1.32), OIL: 12.01 (+0.34), AGF: 13.35 (+0.28), OLEM: 25.07 (+0.30), RIO: 49.37 (+2.22), JJC: 31.11 (+0.06), JJA: 40.54 (+0.51), AGA: 25.56 (-0.39), USO: 19.62 (+0.44), UCO: 9.19 (+0.39), DBA: 23.57 (+0.21), RGRA: 18.94 (-0.07), DTO: 81.31 (-5.12), ADZ: 33.50 (unch), USAG: 21.03 (+0.12), UWTI: 3.71 (+0.23), CUPM: 28.84 (unch), SCO: 70.05 (-3.45), RJA: 7.09 (+0.08), DIRT: 36.61 (+0.42), FUD: 21.37 (+0.21), CPER: 17.69 (+0.33), SZO: 60.00 (-4.31), DBO: 14.88 (+0.08), DWTI: 95.90 (-7.40), USL: 26.81 (+0.40)

Wall Street Breakfast: Greek Exit Fears Rise
Wall Street Breakfast - at Seeking Alpha - Mon Jan 05, 5:31AM CST

GFIG: 6.03 (-0.03), OAK: 57.07 (+1.39), EVC: 7.09 (-0.07), DWA: 20.72 (+0.34), BGCP: 9.34 (+0.19), CME: 93.92 (-1.39), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), AAL: 48.39 (+0.51), BP: 41.93 (+0.59), NDAQ: 49.48 (-0.27)

Glencore to resume Australia coal production
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 3:46AM CST

KOL: 14.24 (+0.27)

BHP Billiton, Rio Tinto move to dominate in copper
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 4:57PM CST

VALE: 8.05 (+0.32), BHP: 51.19 (+2.38), FCX: 20.29 (+0.82), RIO: 49.37 (+2.22)

Strike ends at major Peru copper mine
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 10:42AM CST

TCK: 15.37 (+0.38), BHP: 51.19 (+2.38)

Rio, BHP to echo strategy in copper market
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 12:55AM CST

SCCO: 30.43 (+0.30), CPER: 17.69 (+0.33), CU: 17.35 (+0.60), TCK: 15.37 (+0.38), BHP: 51.19 (+2.38), FCX: 20.29 (+0.82), COPX: 7.00 (+0.25), CUPM: 28.84 (unch), RIO: 49.37 (+2.22), JJC: 31.11 (+0.06)

Glencore weighs 2015 buyback against other opportunities
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 10:33AM CST

Rio Tinto-Glencore a "poor strategic match," CEO Walsh says
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 2:45PM CST

RIO: 49.37 (+2.22)

Glencore signs agreement to end South African ferrochrome strike
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 6:57AM CST

Glencore, Peabody to combine two neighboring Australian coal mines
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 6:57AM CST

BTU: 7.65 (+0.46)

Glencore-Rio Tinto merger will happen, hedge funds told
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 5:28PM CST

RIO: 49.37 (+2.22)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AtWork Welcomes Franchise Vet Sarah Goehring

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Maven Pet's AI Paw-tnership: Changing Pet Care Landscape

AI in the World of Doggie Docs In today's tech-driven world, pet owners are turning to artificial intelligence like never before. Forget flipping through outdated dog-care books—nearly half of us are drilling ChatGPT for health tips on our four-legged pals. Yes, it seems we’re asking an AI about Rover's health more than some other major life decisions. But let's face...

Franco-Nevada's Q3 Results Loom: Investors Ready

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...

CMC Declares Dividend Amid Complex Outlook

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Paradigm Therapeutics: A Beacon in Rare Diseases

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Laars Welcomes Women in Manufacturing to Facility Tour

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Home Buying: Unmasking All the Real Budget Costs

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...